AesthetiCare launches Emepelle as a solution for menopausal skin
Published
02nd Apr 2019
AesthetiCare has launched Emepelle, a new class of cosmeceutical to safely and effectively rejuvenate, restore and rebalance skin affected by menopause.
Available from April 1, Emepelle® is powered by MEP Technology®, a patented, non-hormonal ingredient which is clinically proven to reinvigorate the natural functions of skin affected by low oestrogen levels during menopause.
In clinical studies MEP Technology® has been proven to be safe and effective in helping to address the effects that declining oestrogen levels, caused by menopause, has on the skin, significantly improving hydration, luminosity, elasticity, and appearance of lines and wrinkles. By combining MEP with a synergistic blend of advanced ingredients, Emepelle® helps rejuvenate, restore and rebalance.
The Emepelle range includes two products: Emepelle Serum, and Emepelle Night Cream. Both products are suitable for all skin types and are recommended for women who are in perimenopause, menopause or post menopause.
